Cybin Inc. (OTCMKTS:CLXPF – Get Free Report)’s stock price rose 5.4% on Tuesday . The company traded as high as $10.65 and last traded at $10.65. Approximately 206,199 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 551,962 shares. The stock had previously closed at $10.10.
Cybin Price Performance
The business’s 50-day moving average price is $10.18 and its two-hundred day moving average price is $5.64. The firm has a market cap of $1.58 billion and a price-to-earnings ratio of -44.38.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
See Also
- Five stocks we like better than Cybin
- Consumer Staples Stocks, Explained
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
